241 related articles for article (PubMed ID: 21422850)
21. Cycle and hormone changes during perimenopause: the key role of ovarian function.
Burger HG; Hale GE; Dennerstein L; Robertson DM
Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
[TBL] [Abstract][Full Text] [Related]
22. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
23. Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.
Sahmay S; Demirayak G; Guralp O; Ocal P; Senturk LM; Oral E; Irez T
J Assist Reprod Genet; 2012 Jul; 29(7):589-95. PubMed ID: 22492221
[TBL] [Abstract][Full Text] [Related]
24. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.
Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ
Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952
[TBL] [Abstract][Full Text] [Related]
25. Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women.
Muttukrishna S; Child T; Lockwood GM; Groome NP; Barlow DH; Ledger WL
Hum Reprod; 2000 Mar; 15(3):549-56. PubMed ID: 10686195
[TBL] [Abstract][Full Text] [Related]
26. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.
Su HI; Sammel MD; Green J; Velders L; Stankiewicz C; Matro J; Freeman EW; Gracia CR; DeMichele A
Cancer; 2010 Feb; 116(3):592-9. PubMed ID: 19918920
[TBL] [Abstract][Full Text] [Related]
27. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.
Fanchin R; Schonäuer LM; Righini C; Guibourdenche J; Frydman R; Taieb J
Hum Reprod; 2003 Feb; 18(2):323-7. PubMed ID: 12571168
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
[TBL] [Abstract][Full Text] [Related]
29. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.
Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
Menopause; 2008; 15(6):1139-44. PubMed ID: 18779761
[TBL] [Abstract][Full Text] [Related]
30. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
31. Early follicle development during the luteal-follicular transition affects the predictability of serum follicle-stimulating hormone but not antimüllerian hormone levels on cycle day 3.
Grynberg M; Genro V; Gallot V; El-Ali A; Frydman R; Fanchin R
Fertil Steril; 2010 Oct; 94(5):1827-31. PubMed ID: 19878941
[TBL] [Abstract][Full Text] [Related]
32. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
33. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
34. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.
Janse F; Donnez J; Anckaert E; de Jong FH; Fauser BC; Dolmans MM
J Clin Endocrinol Metab; 2011 Apr; 96(4):1136-44. PubMed ID: 21289248
[TBL] [Abstract][Full Text] [Related]
35. Testicular function in a birth cohort of young men.
Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
[TBL] [Abstract][Full Text] [Related]
36. Fecundability in relation to use of mobile computing apps to track the menstrual cycle.
Stanford JB; Willis SK; Hatch EE; Rothman KJ; Wise LA
Hum Reprod; 2020 Oct; 35(10):2245-2252. PubMed ID: 32910202
[TBL] [Abstract][Full Text] [Related]
37. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.
van Rooij IA; Tonkelaar Id; Broekmans FJ; Looman CW; Scheffer GJ; de Jong FH; Themmen AP; te Velde ER
Menopause; 2004; 11(6 Pt 1):601-6. PubMed ID: 15545787
[TBL] [Abstract][Full Text] [Related]
38. Antimullerian hormone and obesity: insights in oral contraceptive users.
Steiner AZ; Stanczyk FZ; Patel S; Edelman A
Contraception; 2010 Mar; 81(3):245-8. PubMed ID: 20159182
[TBL] [Abstract][Full Text] [Related]
39. Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.
Zarek SM; Mitchell EM; Sjaarda LA; Mumford SL; Silver RM; Stanford JB; Galai N; White MV; Schliep KC; DeCherney AH; Schisterman EF
J Clin Endocrinol Metab; 2015 Nov; 100(11):4215-21. PubMed ID: 26406293
[TBL] [Abstract][Full Text] [Related]
40. Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis.
Kline JK; Kinney AM; Levin B; Kelly AC; Ferin M; Warburton D
Hum Reprod; 2011 Jun; 26(6):1537-50. PubMed ID: 21467203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
